VR Logo

Dishman Carbogen Amcis Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2007

Chairman: Janmejay R Vyas

Managing Director: Arpit J Vyas

Group: Dishman Pharma

Listing: NSE: DCAL, BSE: 540701

Headquarters: Ahmedabad, Gujarat

Website: www.dishmangroup.com

Key Facts

Market cap: R 1,123.92 Cr

Revenue (TTM): R 2,181.21 Cr

Earnings (TTM): R 184.11 Cr

Cash: R 115.39 Cr

Total Debt: R 1,042.17 Cr

Promoters' ownership: 63.17%

Liquidity: High

52 Week range: R 46.05 - 258.15

Face value: R2.00

Shares outstanding: 15,70,81,506

7 Years Aggregate:

  • CFO: 807.29 Cr
  • EBITDA: 1,444.94 Cr
  • Net Profit: 511.50 Cr

Stock Performance

Time Period Dishman Carbogen Amcis S&P BSE Healthcare S&P BSE Small Cap
YTD-16.9417.93-15.54
1 month-16.253.294.22
3 months-5.5913.75-15.99
1 Year-70.7617.97-22.54
3 Years--4.50-8.90
5 Years---0.111.33
10 Years--11.122.98
As on 03-Jun-2020
Year Dishman Carbogen Amcis S&P BSE Small Cap S&P BSE Healthcare
2019-63.80-6.85-3.55
2018-28.94-23.41-5.89